Wiley, Experimental Dermatology, 5(23), p. 366-368, 2014
DOI: 10.1111/exd.12405
Full text: Download
Sezary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma. Recurrent chromosomal aberrations have been found in SS, but the whole genetic mutation spectrum is unknown. To better understand the molecular pathogenesis of SS, we performed exome sequencing, copy number variation (CNV) and gene expression analysis of primary SS cells. In our index patient with typical SS, we found novel somatic missense mutations in TBL1XR1, EPHA7 and SLFN12 genes in addition to larger chromosomal changes. The mutations are located in biologically relevant genes affecting apoptosis and T-cell maturation. They may play a role in the pathobiology of the disease, but no recurrent mutations were discovered in nine additional SS patients studied. Thus, screening of larger patient cohorts are needed to confirm their prevalence and biological significance in SS. This article is protected by copyright. All rights reserved.